Advertisement
Screener

GLOBEIMMUNE INC Net Change in Cash

GLOBEIMMUNE INC Net Change in Cash

GLOBEIMMUNE INC reported Net Change in Cash of -$1.21 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.

Discontinued › Cash Flow

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2016-05-12

  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-31 was -$1.21M.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for the quarter ending 2015-12-31 was -$1.39M.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for the quarter ending 2015-09-30 was -$1.07M, a 108.60% decline year-over-year.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for the quarter ending 2015-06-30 was -$1.99M.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$6.91M, a 163.48% decline from fiscal 2014.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for fiscal 2014 was $10.89M, a 177.67% increase from fiscal 2013.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for fiscal 2013 was $3.92M.
  • GLOBEIMMUNE INC cash and cash equivalents, period increase (decrease) for fiscal 2012 was -$13.15M.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2016-03-31-$1.21M
10-Q · filed 2016-05-12
-$2.60M
derived: sum of 2 quarters · filed 2016-05-12
-$3.67M
derived: sum of 3 quarters · filed 2016-05-12
-$5.66M
derived: sum of 4 quarters · filed 2016-05-12
2015-12-31-$1.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
-$2.46M
derived: sum of 2 quarters · filed 2016-03-16
-$4.46M
derived: sum of 3 quarters · filed 2016-03-16
-$6.91M
10-K · filed 2016-03-16
2015-09-30-$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
-$3.06M
derived: sum of 2 quarters · filed 2015-11-13
-$5.52M
10-Q · filed 2015-11-13
-$7.60M
derived: sum of 4 quarters · filed 2016-05-12
2015-06-30-$1.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14
-$4.45M
10-Q · filed 2015-08-14
-$6.53M
derived: sum of 3 quarters · filed 2016-05-12
$5.90M
derived: sum of 4 quarters · filed 2016-05-12
2015-03-31-$2.46M
10-Q · filed 2016-05-12
-$4.54M
derived: sum of 2 quarters · filed 2016-05-12
$7.89M
derived: sum of 3 quarters · filed 2016-05-12
$5.14M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$2.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
$10.35M
derived: sum of 2 quarters · filed 2016-03-16
$7.60M
derived: sum of 3 quarters · filed 2016-03-16
$10.89M
10-K · filed 2016-03-16
2014-09-30$12.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$9.68M
derived: sum of 2 quarters · filed 2015-11-13
$12.97M
10-Q · filed 2015-11-13
$13.06M
derived: sum of 4 quarters · filed 2016-03-16
2014-06-30-$2.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14
$537.50K
10-Q · filed 2015-08-14
$623.54K
derived: sum of 3 quarters · filed 2016-03-16
$6.13M
derived: sum of 4 quarters · filed 2016-03-16
2014-03-31$3.29M
10-Q · filed 2015-05-14
$3.38M
derived: sum of 2 quarters · filed 2016-03-16
$8.88M
derived: sum of 3 quarters · filed 2016-03-16
2013-12-31$86.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
$5.59M
derived: sum of 2 quarters · filed 2016-03-16
$3.92M
10-K · filed 2016-03-16
2013-09-30$5.51M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2014-11-12
$3.84M
10-Q · filed 2014-11-12
2013-06-30-$1.67M
10-Q/A · filed 2014-09-05
2012-12-31-$13.15M
10-K · filed 2015-03-17